| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
736,983
|
625,842
|
613,279
|
615,222
| | Cost of Revenue | 439,250 | 397,922 | 389,889 | 382,804 | | |
Gross Profit
|
297,733
|
227,920
|
223,390
|
232,418
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 144,840 | 143,178 | 123,015 | 121,267 |
|
Non Recurring | 2,365 | 1,059,579 | 1,618 | 2,210 |
|
Others | 70,071 | 63,207 | 50,409 | 50,702 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
80,457
|
(1,038,044)
|
48,348
|
58,239
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,174 | 348 | 272 | 408 |
|
Earnings Before Interest And Taxes | 81,631 | (1,037,696) | 48,620 | 58,647 |
|
Interest Expense | 95,682 | 87,273 | 74,115 | 64,788 |
|
Income Before Tax | (14,051) | (1,124,969) | (25,495) | (6,141) |
|
Income Tax Expense | (2,424) | (213,192) | (8,413) | (5,450) |
|
Minority Interest | 4,343 | 11,879 | 1,286 | 1,668 |
|
|
|
Net Income From Continuing Ops | (7,284) | (899,898) | (15,796) | 977 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(7,284)
|
(899,898)
|
(15,796)
|
977
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(7,284)
|
(899,898)
|
(15,796)
|
977
|
|